MGTX

MeiraGTx Holdings plc

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$8.79

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %20.1 / %30

Non-compliant assets / Total market cap %8 / %30

Non-compliant revenue / Total income %0.3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia.

Website

Analysis (Turkish): MGTX Hissesi Caiz mi, Helal mi? MeiraGTx Holdings plc Katılım Analizi